MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6402-421-429$20.00
Mol Pharmacol 64:421-429, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skrzydelski, D.
Right arrow Articles by Pelaprat, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skrzydelski, D.
Right arrow Articles by Pelaprat, D.

Differential Involvement of Intracellular Domains of the Rat NTS1 Neurotensin Receptor in Coupling to G Proteins: A Molecular Basis for Agonist-Directed Trafficking of Receptor Stimulus

Delphine Skrzydelski, Anne-Marie Lhiaubet, Antony Lebeau, Patricia Forgez, Misa Yamada1, Emmanuel Hermans, William Rostene, and Didier Pelaprat

Institut National de la Santé et de la Recherche Médicale, Unité 339, Hôpital Saint-Antoine, Paris, France (D.S., A.-M.L., A.L., P.F., M.Y., W.R., D.P.); and Laboratoire de Pharmacologie Expérimentale, Université Catholique de Louvain 54.10, Brussels, Belgium (E.H.)

In this work, we evidenced characteristic features of agonist-induced trafficking of receptor stimulus for the rat neurotensin receptor 1 (NTS1). Thus, reverse potency orders between two agonists, EISAI-1 and neuromedin N, were observed in inositol 1,4,5-trisphosphate and cAMP assays in Chinese hamster ovary cells transfected with this receptor. Indeed, compared with other agonists, EISAI-1 presented lower relative potency toward inositol 1,4,5-trisphosphate production than toward cAMP accumulation, guanosine 5'-O -(3-[35 S]thio)triphosphate binding, and [3H]arachidonic acid production. These results indicated pathway-dependent differences in EISAI-1 intrinsic efficacies, favoring activations of Gs- and Gi/o-related pathways over the Gq/11-related pathway. Moreover, although coupling to Gq/11 and Gi/o involved the third intracellular loop and the C-terminal domain of the NTS1 receptor, respectively, we demonstrated that deletion of the latter domain suppressed agonist-induced cAMP accumulation, suggesting that this domain also mediated coupling to Gs. Together, these results indicated that, unlike other agonists, EISAI-1 discriminated between the pathways involving the receptor C-terminal domain and that involving the third intracellular loop. These properties of EISAI-1 were also observed in cortical neurons endogenously expressing the NTS1 receptor. They were further attributed to the functionalization of its COOH end by an ethyl group, because the unesterified analog EISAI-2 presented normal behavior on inositol 1,4,5-trisphosphate production.

These findings support the hypothesis of agonist-selective receptor states with distinct conformations or accessibilities of intracellular domains. They also suggest that the differential involvement of these domains in coupling to G proteins might represent a molecular basis for agonist-selective responses through G protein-coupled receptors.


Received December 16, 2002; accepted April 30, 2003

Address correspondence to: Dr. D. Pelaprat, INSERM U339, Hôpital Saint-Antoine, 184 rue du faubourg Saint-Antoine, 75571 Paris Cedex 12, France. E-mail: pelaprat{at}st-antoine.inserm.fr




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. R. Moya, K. A. Berg, M. A. Gutierrez-Hernandez, P. Saez-Briones, M. Reyes-Parada, B. K. Cassels, and W. P. Clarke
Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1054 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. M. Perez and S. S. Karnik
Multiple Signaling States of G-Protein-Coupled Receptors
Pharmacol. Rev., June 1, 2005; 57(2): 147 - 161.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Mukhopadhyay and A. C. Howlett
Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions
Mol. Pharmacol., June 1, 2005; 67(6): 2016 - 2024.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. J. Rashid, B. F. O'Dowd, and S. R. George
Minireview: Diversity and Complexity of Signaling through Peptidergic G Protein-Coupled Receptors
Endocrinology, June 1, 2004; 145(6): 2645 - 2652.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics